Alliance Pharma Plc
| London Stock Exchange: APH
Alliance Pharma Plc operates as a pharmaceutical company. It manufactures, develops, markets and distributes pharmaceutical products. Alliance's principal activities are the acquisition and licensing of mature pharmaceutical products and the marketing of those products. Its key products includes, Deltacortril, Nu-Seals, Forceval Capsules, Immucyst and Hydromol. The company was founded by John Dawson in 1996 and is headquartered in Chippenham, the United Kingdom.